טוען...
Update on corticosteroids for diabetic macular edema
Diabetic macular edema (DME) remains an important cause of visual loss. Although anti-vascular endothelial growth factor (VEGF) agents are generally used as first-line treatments for patients with center-involving DME, there is an important role for corticosteroids as well. Corticosteroids may be es...
שמור ב:
| הוצא לאור ב: | Clin Ophthalmol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5019446/ https://ncbi.nlm.nih.gov/pubmed/27660409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S115546 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|